Total amount: € 0,00
Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,632
Online ISSN 1827-191X
Morishita A., Kitamura M., Noji S., Aomi S., Endo M., Koyanagi H.
Department of Cardiovascular Surgery The Heart Institute of Japan Tokyo Women’s Medical University, Tokyo, Japan
Background. Although some surgeons prefer to use artificial valve rings for tricuspid valve annuloplasty, we have mainly performed De Vega’s tricuspid annuloplasty for functional tricuspid regurgitation, because it is a simple and effective technique for reducing tricuspid regurgitation due to annular dilatation. We evaluated long-term results of the De Vega’s tricuspid annuloplasty up to 19 postoperative years.
Methods. Between January 1980 and June 1999, 408 patients underwent De Vega’s tricuspid annuloplasty. Long-term results after De Vega’s tricuspid annuloplasty were analyzed.
Results. There were 14 (3.4%) early deaths within 30 postoperative days. There were 63 (15.4%) late deaths during the follow-up period. The actuarial survival rate at 15 years after operation was 74.0%, the 15-year freedom from re-operation was 91.6%, and the 15-year freedom from all events was 58.7%, respectively.
Conclusions. These results suggest that De Vega’s tricuspid annuloplasty was an effective and reliable procedure of choice for secondary tricuspid regurgitation with annular dilatation.